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In mammals, UVB radiation is of biological relevance primarily for the cells of the epidermis. We report here
the existence of a UVB response that is specific for proliferating human epidermal keratinocytes. Unlike other
cell types that also display a UVB response, keratinocytes respond to UVB irradiation with a transient but
potent downregulation of the Ras–extracellular signal-regulated kinase (ERK) signaling cascade. The down-
regulation of ERK precedes a profound decrease in the steady-state levels of cyclin D1, a mediator of the
proliferative action of ERK. Keratinocytes exhibit high constitutive activity of the Ras-ERK signaling cascade
even in culture medium lacking supplemental growth factors. The increased activity of Ras and phosphory-
lation of ERK in these cells are maintained by the autocrine production of secreted molecules that activate the
epidermal growth factor receptor (EGFR). Irradiation of keratinocytes increases the phosphorylation of EGFR
on tyrosine residues Y845, Y992, Y1045, Y1068, Y1086, Y1148, and Y1173 above the basal levels and leads to
the increased recruitment of the adaptor proteins Grb2 and ShcA and of a p55 form of the regulatory subunit
of the phosphatidylinositide 3-kinase to the UVB-activated EGFR. Paradoxically, however, UVB causes, at the
same time, the inactivation of Ras and a subsequent dephosphorylation of ERK. By contrast, the signaling
pathway leading from the activated EGFR to the phosphorylation of PKB/Akt1 is potentiated by UVB. The UVB
response of keratinocytes appeared to be a manifestation of the more general ribotoxic stress response
inasmuch as the transduction of the UVB-generated inhibitory signal to Ras and ERK required the presence
of active ribosomes at the time of irradiation.
Exposure to UVB radiation is the major cause of cutaneous
malignancies in the United States (45). UVB is a complete
carcinogen that is known to act both as a tumor initiator and a
tumor promoter (43, 59). Exposure of the skin to UVB induces
the stereotypic early responses of genes such as c-fos and c-jun
(6, 26, 27, 63) and delayed responses, including hyperplasia
and skin cancer (21, 26, 48, 72). The induction of the early
response genes results from a cascade of signaling events that
eventually modulates the activity of specific transcription fac-
tors. The signaling pathways that transduce UVB-initiated sig-
nals to modulate gene expression involve the superfamily of the
proline-directed mitogen-activated protein (MAP) kinases (6,
55). The stress-activated protein kinase (SAPK) family of
MAP kinases includes the c-Jun-NH2-terminal kinases (JNK;
SAPK1) and the p38 MAP kinases (SAPK2) (15, 46, 73). The
activation of SAPK in mammalian cells leads to decision mak-
ing via the activation of competing prosurvival and proapop-
totic pathways (15). Activation of SAPK has also been shown
to be a major pathway leading to the synthesis and release of
proinflammatory cytokines, which function to communicate
the presence of cellular damage to other cells of the organism
(16, 57). The extracellular signal-regulated kinases, p44 ERK1
and p42 ERK2 (ERKs), represent the other family of MAP
kinases. Although ERKs may play specific roles in specific cell
types, it is generally accepted that mitogen-induced sustained
activation of ERKs mediates cell cycle progression through G1-
and S-phase entry by regulating the expression of cyclin D1 (2,
3, 12, 60, 66, 76).
The epidermal growth factor receptor (EGFR) plays a cru-
cial role in mediating both the proliferative and prosurvival
programs of keratinocytes, the main cell type of the epidermis
(reference 68 and references therein). At least five mitogenic
growth factors bind to and activate EGFR in the skin. In
addition to epidermal growth factor (EGF), these factors in-
clude transforming growth factor  (TGF-) (11), amphiregu-
lin (13), heparin-binding EGF (HB-EGF) (25), and epiregulin
(67). The classical signal-transduction cascade that translates
EGFR activation into the increased activity of ERK has been
investigated at length (10, 40, 64). The binding of a cognate
ligand stabilizes receptor dimerization and stimulates the ty-
rosine kinase activity of the intracellular portion of the recep-
tor, resulting in the increased auto(trans-)phosphorylation of
several tyrosine residues within the receptor dimer (7, 65). The
phosphorylated tyrosines serve as recruitment (docking) sites
for several adaptor proteins, among which the adaptor proteins
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Grb2 (19, 42) and Shc (44, 53, 62) are of particular importance
for the activation of ERK (60). Grb2 contains one Src-homol-
ogy 2 (SH2) domain flanked by two Src-homology 3 (SH3)
domains (42). The SH2 domain of Grb2 binds to tyrosine-
phosphorylated residues in growth factor receptors, such as
Y1068 and Y1086 of EGFR (5, 50, 74), whereas the SH3
domains bind to proline-rich motifs found in many signaling
molecules, such as the Son of Sevenless (Sos) protein (9, 19,
52). Sos is a guanine nucleotide exchange factor that facilitates,
in response to activation of growth factor receptors, the con-
version of the inactive (GDP-bound) form of the cell mem-
brane-localized small GTPase Ras into the activated (GTP-
bound) form of Ras (9). Activated Ras recruits to the cell
membrane the serine/threonine protein kinase c-Raf, an event
that leads to the activation of c-Raf itself (37). c-Raf, in turn,
phosphorylates and activates the MAP/ERK kinases MEK1
and MEK2, eventually leading to the activation of ERK (10,
37, 40, 64). Grb2 also binds EGFR indirectly via EGFR-bound
ShcA (4). ShcA, however, binds to different phosphotyrosine
residues of EGFR, namely Y1148, Y1173, and Y992 (4, 5, 49,
74).
The study of the molecular basis of the UV response (en-
compassing the cellular responses to both UVC and UVB) in
a tissue culture system has traditionally been performed in
rodent and human fibroblasts and in HeLa cells (6, 30, 31, 34,
36, 55, 63) under the assumption that the UV response is
conserved in all cell types. By use of NIH 3T3 fibroblasts and
HeLa cells, ERK was identified as the first signal transduction
kinase activated early after exposure to UVC radiation (55).
The identification of the ability of UVC and UVB to trigger
the activation of growth factor receptors (36, 63) favored the
conclusion that an operational growth factor receptor-ERK
cascade is an important mediator of UV-induced gene expres-
sion (6, 26).
In the search for novel and relevant UV-induced signal-
transduction pathways, we recently discovered that the activa-
tion of SAPK by UVC and UVB is initiated in, or in close
proximity to, the functional center of actively translating eu-
karyotic ribosomes (31, 34). This center contains the 3 end of
28S rRNA and its proteinaceous environment and is respon-
sible for aminoacyl-tRNA binding, peptidyl transfer, and ribo-
some translocation. This region of the 28S rRNA is the target
of the antibiotics anisomycin and blasticidin S and of the en-
zymatic ribotoxins ricin A chain and -sarcin, all of which
strongly activate SAPK (reference 33 and references therein).
The activation of SAPK by the foregoing agents was termed
the ribotoxic stress response and is characterized by the abso-
lute requirement for the presence of actively translating ribo-
somes at the moment of cellular encounter with the antibiotic
or ribotoxin acting on 28S rRNA (33). Cells whose ribosomes
are not engaged in translational elongation fail to activate
SAPK in response to these agents. In contrast, the activation of
SAPK by nonribotoxic stressors, such as inflammatory cyto-
kines, osmotic stress, and some DNA-damaging drugs, is intact
in cells containing nontranslating ribosomes (31–33). Interest-
ingly, UVB requires the presence of active ribosomes to acti-
vate SAPK. Furthermore, nucleotide- and position-specific
damage to the 3 end of 28S rRNA was detected in UVB-
irradiated cells, and the time of appearance and degree of this
damage correlated with the activation of SAPK (34). It was
concluded therefore that UVB triggers the ribotoxic stress
response that leads to the activation of SAPK. In cells that
respond to UVB with the activation of ERK (e.g., fibroblasts or
HeLa cells), however, the activation of ERK was not depen-
dent on ribotoxic stress inasmuch as it did not require active
ribosomes (34).
In the present study, we employed normal human keratino-
cytes to investigate whether these cells (that are frequently
exposed to solar radiation) possess a specific UVB response.
We demonstrate for the first time that the UVB response of
human keratinocytes is characterized by both stimulatory (ac-
tivation of SAPK) and inhibitory (inactivation of ERK) signal
transduction components. The elevated basal levels of ERK
activity in these cells resulted from the autocrine and paracrine
actions of extracellular molecules that bind to and activate the
EGFR. Despite the activation of EGFR resulting from UVB
irradiation, UVB interfered with signals that lead to ERK
activation at the level of a signal-transduction step(s) located
downstream of the EGFR-bound Grb2 and ShcA but up-
stream of Ras. At the same time, the activation of EGFR by
UVB triggered the phosphorylation of the protein kinase B
(PKB/Akt1) that is involved in mediating cell survival (14).
Finally, we show that both the stimulatory and the inhibitory
UVB responses of MAP kinases are downstream of a ribo-
some-initiated signaling event.
MATERIALS AND METHODS
Cell culture. Human epidermal keratinocytes, neonatal (HEKn) were main-
tained in EpiLife basal keratinocyte medium (BKM) supplemented with a
semidefined human keratinocyte growth supplement (HKGS) (the final concen-
trations of the components in the supplemented medium were as follows: 0.2%
[vol/vol] bovine pituitary extract, 5 mg of bovine insulin per ml, 0.18 mg of
hydrocortisone per ml, 5 mg of bovine transferrin per ml, and 0.2 ng of human
epidermal growth factor per ml). The BKM supplemented with HKGS is re-
ferred to as BKMexoGF (BKM plus exogenous growth factors), and BKM
lacking HKGS is referred to as BKM–exoGF (BKM minus exogenous growth
factors). The cells and all cell culture reagents were obtained from Cascade
Biologics, Inc. Immortalized HEKn (HEKn-E6/E7) were established through
infection with an amphitropic recombinant retroviral vector encoding the E6 and
E7 transforming proteins of human papillomavirus serotype 16 as previously
described (35). HEKn-E6/E7 were maintained in culture in a way identical to
what was done with HEKn. The HaCaT cell line (a gift from Tim Bowden) and
HeLa cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% fetal calf serum and antibiotics. For experiments, Ha-
CaT and HeLa cells were plated in BKMexoGF.
Irradiation of cells and other treatments. The spectral characterization of the
UVB source and the mode of the irradiation of cells with UVB have been
described previously (31, 34). Human recombinant EGF (Sigma) was kept as a
100-g/ml stock solution in 5  103 N HCl at 70°C. AG1478 and UO126
(both from Calbiochem), anisomycin, emetine, actinomycin D (all from Sigma),
and pactamycin (a gift from Pharmacia and Upjohn) were dissolved in dimethyl
sulfoxide (DMSO) and kept at 70°C. Sodium arsenite (Sigma) was freshly
prepared before use as a 40 mM stock solution in double-distilled deionized
water. To prepare conditioned media, the cells (originally plated in
BKMexoGF) were washed extensively with BKM–exoGF and then placed for
20 to24 h in BKM–exoGF (2 ml for each 60-mm-diameter cell culture plate).
Conditioned media were never frozen and were used only once. The EGFR-
neutralizing monoclonal antibody LA1 was obtained from Upstate Biotechnol-
ogy.
Immunocomplex kinase assay. HEKn from 6-cm-diameter tissue culture
dishes were harvested by lysis on ice in an ice-cold solution containing 20 mM
HEPES-KOH (pH 7.4), 2 mM EGTA, 50 mM -glycerophosphate, 1 mM di-
thiothreitol (DTT), 10% glycerol, 1% Triton X-100, 1 mM sodium vanadate, and
1 Complete protease inhibitors (Roche Molecular Biochemicals). ERK1/
ERK2 was immunoprecipitated for 3 h at 4°C with an anti-ERK1/ERK2 antibody
(C-16; Santa Cruz Biotechnology) precoupled to protein A-agarose (Santa Cruz
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Biotechnology). The immunoprecipitates were washed once with lysis buffer;
once with a solution consisting of 100 mM Tris-HCl (pH 7.6), 500 mM LiCl, 1
mM DTT, and 0.1% Triton X-100; and once with a buffer containing 20 mM
morpholinepropanesulfonic acid (MOPS; pH 7.2), 10 mM MgCl2, 2 mM EGTA,
1 mM DTT, and 0.1% Triton X-100. For the kinase reaction, the immunopre-
cipitates were incubated with 1 mg of glutathione S-transferase (GST)–Elk1
fusion proteins in the presence of 10 mM MOPS (pH 7.2), 20 mM MgCl2, 1 mM
EGTA, 0.5 mM DTT, 0.05% Triton X-100 and 1 mCi of [-32P]ATP for 20 min
at 30°C. After the reactions were stopped by adding 10 l of 4 sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) loading buffer, the sam-
ples were resolved by SDS–13% PAGE. The phosphorylated GST-Elk1 was
quantified from dried gels with a Molecular Dynamics PhosphorImager and IP
Lab Gel software.
Immunoblot analysis of proteins. For immunoblot analyses, the cells were
lysed directly in 2 SDS-PAGE loading buffer and lysates corresponding to 1 
105 to 1.5  105 cells were resolved in SDS-PAGE with the appropriate per-
centage of acrylamide (7.5 to 15%). The antibodies against ERK1 (C-16), EGFR
(EGFR-1005), the phosphorylated form of EGFR (pY1173), Sos1 (C-23 and
D-21), ShcA (PG-797), c-Myc (N-262), p63 (4A4-HRP), p53 (DO-1-HRP), cy-
clin D1 (M-20), MEK2 (N-20), JNK1 (C-17), p38 MAP kinase (C-20), p85 PI-3K
(Z-8), and PKB/Akt1/2 (H-136) were obtained from Santa Cruz Biotechnology.
The antibodies against the phosphorylated forms of EGFR (pY1148 and
pY1086) were obtained from BioSource International. The antibodies against
the phosphorylated forms of EGFR (pY845, pY992, pY1045, and pY1068) were
obtained from Cell Signaling Technology. The pan-Ras antibody (31–43) was
obtained from Calbiochem. The antibodies against the phosphorylated forms of
ERK, p38 MAP kinase, JNK, MEK, PKB/Akt1 (S473), and FKHR were ob-
tained from Cell Signaling Technology. The antibody against Grb2 was obtained
from BD-Transduction Laboratories. The separation of proteins in SDS-PAGE
and the electrotransfer onto polyvinylidene difluoride membranes (Millipore)
were performed by standard procedures. Immunodetections with phospho-
epitope-specific antibodies were performed according to the instructions of the
respective manufacturers.
Coimmunoprecipitations. The coimmunoprecipitation of EGFR with associ-
ated proteins was performed as described by Dulin et al. (17), and the coimmu-
noprecipitation of Sos1 with associated proteins was performed as described by
Gross et al. (23).
Ras activity assay. Recombinant protein composed of the Ras-binding domain
of c-Raf fused to GST (GST/Raf-RBD; a gift from Rudolf Juliano) was bacte-
rially expressed in advance, affinity bound to glutathione-coupled Sepharose 4B
beads (Amersham Pharmacia Biotech AB) shortly before use, and kept on ice.
All subsequent procedures were performed with the protein on ice or at 4°C.
Cells were lysed by scraping and vigorous mixing in 1 ml (on a 100-mm-diameter
cell culture plate) of lysis buffer (50 mM Tris [pH 8.0], 150 mM NaCl, 1%
IGEPAL [Sigma; equivalent to Nonidet P-40], 10% glycerol, 5 mM MgCl2, 10
mM NaF, 1 mM NaVO4, 1 Complete protease inhibitors [Roche Molecular
Biochemicals], and 1 M DTT). The lysates were precleared for 10 min at 14,000
rpm in an Eppendorf table-top centrifuge. One hundred microliters of GST/Raf-
RBD-bound slurry was mixed with cell lysate (typically corresponding to 3  106
to 4  106 cells per experimental point) and incubated, with continuous mixing,
for 30 min. After the beads were washed three times with lysis buffer, GTP-
bound Ras proteins were eluted by boiling in 100 l of 2 SDS-PAGE loading
buffer. Ras proteins were resolved with SDS-15% PAGE and detected by im-
munoblot analysis.
RESULTS
Inactivation of ERK by UV in human epidermal keratino-
cytes. In order to investigate the regulation of MAP kinases by
UVB in a cell type that naturally encounters UV radiation, we
employed freshly explanted HEKn. We also employed un-
cloned HEKn-E6/E7 (see Materials and Methods). Both
HEKn and HEKn-E6/E7 display the expression of basal ker-
atinocyte markers (	Np63) (54, 77) (Fig. 2A, lanes 1 and 6)
and integrin  1 (75) (data not shown). When cultured in
serum-free BKMexoGF (see Materials and Methods), both
HEKn and HEKn-E6/E7 displayed detectable levels of double-
phosphorylated p42 ERK2 and, to a much lesser extent, p44
ERK1 (Fig. 1A, lane 1, and B, lane 1), as detected in immu-
noblot assays with phosphorylation-specific antibodies. To in-
vestigate the regulation of ERK activity by UV in keratino-
cytes, we subjected HEKn and HEKn-E6/E7 to UVB.
Irradiation of HEKn and HEKn-E6/E7 induced a dose-depen-
dent increase in the phosphorylation of SAPK (JNK and p38
MAP kinase) at 30 min postirradiation (Fig. 1A and B, lanes 1
to 5 of each). Surprisingly, we found that, instead of activation,
UVB-irradiated HEKn and HEKn-E6/E7 displayed a dose-
dependent downregulation of the phosphorylation state of
ERK at 30 min postirradiation (Fig. 1A and B, lanes 1 to 5 of
each). The dephosphorylation of ERK in HEKn (Fig. 1A)
occurred after doses of UVB (600 to 1,200 J/m2) that caused
both cell cycle withdrawal (evident by an inhibition of DNA
synthesis [data not shown] and a decrease in the steady-state
levels of c-Myc [Fig. 2B]) and apoptosis (“sunburn cells” [38,
47]) [evident by the cleavage of the caspase substrate poly-
(ADP)ribose polymerase (Fig. 2A) and the decrease in the
steady-state levels of 	Np63 (41) (Fig. 2A)]. The UVB-in-
FIG. 1. Dose-dependent regulation of the phosphorylation of MAP
kinases by UVB. HEKn and HeLa cells (A) and HEKn-E6/E7 and
HaCaT cells (B) (grown in BKMexoGF) were treated with the in-
dicated doses of UVB and were harvested 30 min later. Shown are the
results of immunoblot analyses using phosphorylation-specific antibod-
ies against the indicated proteins.
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duced dephosphorylation of ERK resulted in a substantial
inhibition of ERK activity (93% 
 2% inhibition) as deter-
mined by immunocomplex kinase activity assays 30 min postir-
radiation (Fig. 2B). The dephosphorylation and inactivation of
ERK following exposure to UVB became detectable 20 min
after the irradiation (Fig. 3A, lane 3) and persisted, with some
variation from experiment to experiment, for typically 2 to 6 h
after irradiation (Fig. 3A, lanes 3 to 10). The UV-induced
inactivation of ERK has been observed invariably in all six
independent preparations of HEKn (each derived from a dif-
ferent individual) that we have examined. For instance, Fig.
1A, 3A, and 9 depict the UVB responses of three independent
HEKn preparations (i.e., three different individuals). ERK1
and ERK2 proteins were expressed at similar steady-state lev-
els in HEKn and HEKn-E6/E7, and these levels were not
affected by exposure to UVB (Fig. 1, 3, 5, 6A, 7, 8, 10, 11, and
12A). Therefore, the decrease in ERK phosphorylation and
activity after exposure to UV was due to a bona fide dephos-
phorylation event and not to reduced ERK levels. In summary,
these results demonstrated that, in contrast to what occurs in
other cell types that have been investigated, the activity of
ERK in keratinocytes was transiently, but potently, suppressed
in response to UVB.
Human epidermal keratinocytes maintain high steady-state
levels of ERK activity via the autocrine production of EGFR
ligand(s). To determine whether the phosphorylated state of
ERK in keratinocytes was due to the presence of supplemental
growth factors in BKMexoGF, we assessed the phosphory-
lation status of ERK after placing HEKn or HEKn-E6/E7 in
BKM–exoGF for 20 h. The absence of exogenously supplied
FIG. 2. (A) Effects of UVB irradiation on cell cycle and apoptosis
markers in HEKn and HEKn-E6/E7. Cells grown in BKMexoGF
were irradiated with the indicated doses of UVB, and the expression of
the indicated proteins was determined in immunoblot analyses 21 h
postirradiation. PARP, poly(ADP)ribose polymerase. (B) Inhibition of
ERK activity by UVB and anisomycin. HEKn (grown in
BKMexoGF) were treated with UVB (1,200 J/m2) or anisomycin (10
g/ml). ERK activity was assessed 30 min later in immunocomplex
kinase assays (see Materials and Methods). Lane 4 of the boxed insert
shows the control immunoprecipitation (IP) with an irrelevant anti-
body. Error bars represent the standard deviations from experimental
points in triplicates.
FIG. 3. Time-dependent inhibition of ERK phosphorylation by
UVB. Shown are the results of immunoblot analyses using phosphor-
ylation-specific antibodies against the indicated proteins. (A) HEKn
were treated with UVB (1,200 J/m2) UVB and later harvested at the
indicated times. Co, control. (B) HEKn and HEKn-E6/E7, placed 20 h
earlier in either BKMexoGF or BKM–exoGF, were irradiated with
UVB (1,200 J/m2) and harvested at the indicated times after the
irradiation. –, control cells. Note that a prior hybridization of a mem-
brane with antibodies against the phosphorylated forms of ERK or
EGFR interferes with a subsequent hybridization of the same mem-
brane with the antibodies against nonphosphorylated ERK or EGFR
at any location in the membrane where the phospho-specific signal was
strong. This explains the apparent weaker signal of the nonphospho-
rylated p42 ERK2 seen in the bottom panel of lane 6. The same
phenomenon can also be seen in Fig. 4A, lanes 3 and 10 (ERK2); Fig.
5A, lane 2 (EGFR and ERK2); Fig. 6A, lanes 1 to 3 and 7 (ERK2);
Fig. 7A, lanes 5 to 7 (ERK2); Fig 9, panel l, lanes 7 and 12 (ERK2);
and Fig. 12A, lanes 2 to 4 (ERK2).
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growth factors failed to decrease the degree of phosphoryla-
tion of ERK (Fig. 3B, compare lanes 1 and 6), suggesting that
the activity of ERK is regulated by autocrine mechanisms in
these cells. To test this possibility, we transferred HEKn-E6/
E7-conditioned BKM–exoGF onto serum-deprived HeLa
cells, whose levels of ERK phosphorylation are extremely low.
Keratinocyte-conditioned, but not HeLa-cell-conditioned
(data not shown), or unconditioned BKM–exoGF stimulated
the phosphorylation of ERK in the HeLa cells (Fig. 4A, lane
3). Furthermore, only the keratinocyte-conditioned BKM–
exoGF was capable of causing the phosphorylation of EGFR at
tyrosine-1173 (Y1173) (Fig. 4A, lane 3). The keratinocyte-
conditioned BKM–exoGF was unable to induce the phosphor-
ylation of ERK (Fig. 4A, lane 7) when the conditioned medium
was added to HeLa cells that had been pretreated with
AG1478, a specific inhibitor of the EGFR tyrosine kinase ac-
tivity (20, 51). Following the exposure of HeLa cells to kera-
tinocyte-conditioned BKM–exoGF (Fig. 4A, lane 7), the phos-
phorylation of EGFR at Y1173 was also inhibited by AG1478,
suggesting that the receptor phosphorylation was caused by the
tyrosine kinase activity of the receptor itself and not by a
different tyrosine kinase. These results suggest that keratino-
cytes produce a soluble ligand(s) that is capable of activating
EGFR and, subsequently, ERK. These results were not exclu-
sively specific for the immortalized HEKn-E6/E7, since the
mortal HEKn also displayed a potent production of a soluble
FIG. 4. Production of a soluble ligand(s) of EGFR by HEKn-E6/E7 but not by HaCaT cells. Shown are the results of immunoblot analyses using
antibodies specific for the phosphorylated states of EGFR (Y1173) and ERK. (A) The phosphorylation state of EGFR (Y1173) and ERK in HeLa
(lanes 1 to 8) or HaCaT (lanes 9 to 12) cells that have been subjected to unconditioned, HEKn-E6/E7-conditioned, or HaCaT-conditioned
BKM–exoGF according to the method described in the figure body. The cells were pretreated for 30 min with 10 M AG1478 () or the vehicle
solvent DMSO(). (B) HEKn-E6/E7, placed 20 h earlier in either BKMexoGF ( GF) or BKM–exoGF (– GF), were treated with 10 M
AG1478 or the vehicle solvent DMSO (lanes 1 to 6) for the indicated times.
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ligand(s) of EGFR (Fig. 5B). To determine whether this li-
gand(s) provides the main extracellular signal for the high
ERK activity in keratinocytes, we incubated HEKn-E6/E7 with
AG1478 and assessed the phosphorylation status of ERK. Im-
mediately (less than 10 s) after the addition of AG1478, the
keratinocytes displayed an immediate decrease in the basal
phosphorylation of EGFR (Fig. 4B, lane 7) without a concom-
itant decrease in the phosphorylation of ERK. Five minutes
after the addition of AG1478, the basal phosphorylation of
ERK dramatically decreased, and the low levels of phosphor-
ylated ERK persisted for the duration of the experiment (Fig.
4B, lanes 7 to 12). The effect of AG1478 was independent of
the presence or the absence in BKM of supplemental growth
factors (Fig. 4B). To verify the specificity of AG1478, we com-
pared its abilities to inhibit the activation of ERK by EGF and
by fibroblast growth factor 2 (FGF-2). FGF-2 also signals
through a cognate receptor with intrinsic tyrosine kinase activ-
ity but not through EGFR (22). Addition of EGF to cells
pretreated with AG1478 failed to induce the phosphorylation
of either EGFR or ERK (Fig. 5A, lane 5). However, AG1478
had no effect on the ability of FGF-2 to induce the phosphor-
ylation of ERK (Fig. 5A, lane 6) (FGF-2 did display an ability
to trigger the phosphorylation of ERK because the basal phos-
phorylation of ERK had been reduced to very low levels by
AG1478). These results (Fig. 4 and 5) suggested that the ele-
vated activity of ERK in keratinocytes is sustained predomi-
nantly through the autocrine production of a soluble ligand(s)
that activates EGFR. To verify by a different approach that the
ERK activity in keratinocytes is exclusively dependent on the
autocrine-maintained activity of EGFR, we employed the
EGFR-neutralizing monoclonal antibody LA1. Thirty minutes
after the addition of LA1 to the culture medium (BKM–ex-
oGF) of HEKn-E6/E7, the phosphorylation of Y1173 of
EGFR was substantially (albeit not completely) decreased and
the decrease remained unchanged for as long as 6 h (Fig. 6A,
lanes 4 to 6). Importantly, the EGFR-neutralizing antibody
completely blocked the phosphorylation of ERK (Fig. 6A,
lanes 4 to 6) in a manner similar to the effect of AG1478 (Fig.
6A, lane 8).
To investigate whether the supplemental growth factors
present in BKMexoGF influence the dephosphorylation of
ERK by UVB, we irradiated HEKn or HEKn-E6/E7 20 h after
placing the cells in BKM–exoGF. The dephosphorylation of
ERK by UVB was more pronounced in the cells maintained in
BKM–exoGF in terms of both amplitude and duration (Fig.
3B, compare lanes 2 to 5 with lanes 7 to 10). We concluded that
the supplemental growth factors present in BKMexoGF fa-
cilitate the recovery of ERK phosphorylation levels following
exposure to UVB.
The expression of cyclin D1 in keratinocytes is regulated by
the EGFR-MEK-ERK cascade. To investigate the potential
physiological consequences of the UVB-induced inactivation
of ERK in keratinocytes, we studied the steady-state levels of
cyclin D1. Proliferating HEKn (Fig. 3A, lane 1, and 6B, lane 1)
or HEKn-E6/E7 (Fig. 6A, lane 1) displayed detectable levels of
cyclin D1. Following UVB irradiation, the steady-state levels of
cyclin D1 declined gradually within the first 2 h after irradia-
tion and remained low for as long as 6 h (Fig. 3A, lanes 2 to 10,
and 6B, lanes 2 and 3). This was consistent with the withdrawal
of the cells from the cell cycle described above (see the legend
to Fig. 2A). To investigate whether cyclin D1 expression is
determined in keratinocytes by the activity of the EGFR-
MEK-ERK cascade, we studied the effects of AG1478, the
LA1 EGFR-neutralizing antibody, and UO126, a specific in-
hibitor of MEK, on cyclin D1 levels. The levels of cyclin D1
were not affected by short (30 to 60 min) treatments with either
AG1478 or LA1 (Fig. 6A, lanes 4, 5, and 8). However, 6 h after
the application of LA1 (Fig. 6A, lane 6) and 4 h after the
application of AG1478 (Fig. 6B, lane 5) a substantial decrease
in the cyclin D1 levels was evident. Similarly, 4 h after the
application of UO126, we detected a marked decrease in the
expression of cyclin D1 (Fig. 6B, lane 4). Taken together, these
data are strongly consistent with the conclusion that the linear
EGFR-ERK signal transduction cascade is the major determi-
nant of cyclin D1 expression in proliferating keratinocytes.
The UVB-induced inactivation of ERK is specific for kera-
FIG. 5. Human epidermal keratinocytes maintain high steady-state
levels of ERK activity via the autocrine production of EGFR ligand(s).
(A) Results of immunoblot analyses showing that AG1478 inhibits
specifically the EGF-induced signaling but not the FGF-2-induced
signaling to ERK. HEKn-E6/E7 were pretreated for 30 min with 10
M AG1478 (lanes 4 to 6) or the vehicle solvent DMSO (lanes 1 to 3)
and were then treated for 15 min with either EGF (100 ng/ml) or
FGF-2 (20 ng/ml). (B) Immunoblot analyses of the phosphorylation
state of EGFR (Y1173), ERK, and PKB/Akt1 (Ser473) in HaCaT cells
that have been subjected to either HaCaT-conditioned or HEKn-E6/
E7-conditioned BKM–exoGF according to the method described in
the figure body.
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tinocytes. Next, we investigated whether UVB induces the in-
activation of ERK in cells other than keratinocytes. Irradiation
of HeLa cells with UVB in growth medium optimal for HeLa
cells (DMEM, with or without 10% fetal bovine serum) re-
sulted in an increased rather than decreased ERK activity
(data not shown), as was previously reported for UVC (30, 63)
and UVB (34). To investigate the possibility that the type of
growth medium (BKM or DMEM) changes the responsiveness
of ERK to UV, we plated HeLa cells in BKMexoGF and
investigated their response to UVB 24 h later. Even in
BKMexoGF, HeLa cells responded to UVB irradiation with
a dose-dependent increase in ERK phosphorylation (Fig. 1A,
lanes 2 to 5).
The human keratinocyte-derived cell line HaCaT (8) has
been used to study the stress responses of keratinocytes (e.g.,
a literature search revealed 84 articles from 1993 to 2001 deal-
ing with the UV response of HaCaT cells) despite the fact that
these cells have acquired the ability to grow in the presence of
serum and calcium concentrations that are inhibitory for pri-
mary keratinocytes. In contrast to HEKn and HEKn-E6/E7,
HaCaT cells maintained low basal levels of phosphorylated
ERK and responded to UVB irradiation with an increased
(rather than decreased) phosphorylation of ERK (Fig. 1B,
lanes 6 to 10). Identical results were observed when HaCaT
cells were maintained and propagated in DMEM supple-
mented with fetal calf serum (data not shown) or in
BKMexoGF (Fig. 1B). In contrast to the various responsive-
ness of ERK phosphorylation, the phosphorylation of SAPK
(JNK and p38 MAP kinase) was stimulated by UVB in all cell
types tested (HEKn, HEKn-E6/E7, HeLa, and HaCaT) (Fig.
1).
HaCaT cells have lost the ability to produce a ligand(s) that
binds to EGFR. To begin to understand the basis for the
difference in the responsiveness of HEKn and HaCaT cells to
UVB radiation, we determined whether HaCaT cells have lost
the autocrine regulation of the EGFR-ERK signal transduc-
tion pathway that is characteristic of HEKn and HEKn-E6/E7.
A deficiency in producing an autocrine EGFR ligand(s) or in
responding to this ligand(s) may explain the loss of autocrine
regulation characteristic of HaCaT cells. We found that, unlike
the BKM–exoGF conditioned by HEKn-E6/E7 (which induced
an AG1478-inhibitable phosphorylation of EGFR and ERK),
the BKM–exoGF conditioned by HaCaT cells was unable to
induce the phosphorylation of EGFR and ERK in recipient
serum-deprived HeLa cells (Fig. 4A, lanes 3, 4, 7, and 8).
However, growth factor-deprived HaCaT cells responded to
HEKn- or HEKn-E6/E7-conditioned BKM–exoGF with an
AG1478-inhibitable induced phosphorylation of both EGFR
and ERK (Fig. 4A, lanes 9 to 12, and 5B). We concluded
therefore that HaCaT cells have lost the ability to produce
soluble EGFR ligands but not the ability to respond to these
ligands.
UVB interferes with ERK phosphorylation upstream of Ras
but downstream of EGFR. The inhibition of the phosphoryla-
tion of ERK following UVB irradiation of keratinocytes was
paralleled by a similar decrease in the phosphorylation status
of MEK (HEKn [Fig. 3A and see Fig. 9, panel k]; HEKn-
E6/E7 [data not shown]). Keratinocytes display the presence of
a highly active ERK phosphatase(s), as evidenced by the rapid
dephosphorylation of ERK following the application of
AG1478 (Fig. 4B). For this reason, the high steady-state activ-
ity of ERK appears to be critically dependent on the constant
flow of upstream activation signal transmitted by activated
MEK. Therefore, the decrease in MEK phosphorylation fol-
lowing UVB irradiation is likely to be responsible for the
inactivation of ERK. We speculated that UVB might interfere
with the basal activity of MEK and ERK by inhibiting the
kinase activity of EGFR. To test this possibility, we investi-
FIG. 6. Expression of cyclin D1 in keratinocytes is dependent on
the activities of EGFR and MEK. (A) HEKn-E6/E7, placed 20 h
earlier in BKM–exoGF, were left untreated or were treated with the
EGFR-neutralizing antibody (Ab) LA1 (5 g/ml), with AG1478 (10
M), or with DMSO (vehicle control for AG1478). The cells were
harvested at the indicated times, and the expression and/or phosphor-
ylation status of the indicated proteins was assayed in immunoblot
analyses. IgG1(H), the heavy immunoglobulin chain of the neutralizing
anti-EGFR antibody used. (B) HEKn, placed 20 h earlier in BKM–
exoGF, were left untreated or were treated with UVB (1,200 J/m2),
AG1478 (10 M), UO126 (10 M), or the EGFR-neutralizing anti-
body LA1 (5 g/ml). The cells were harvested at the indicated times,
and the expression and/or phosphorylation status of the indicated
proteins was assayed in immunoblot analyses.
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gated the effect of UVB on the basal and EGF-induced ty-
rosine phosphorylation of EGFR in HEKn-E6/E7. Previously,
we had determined that a 0.1-ng/ml dose of EGF is sufficient to
trigger reproducibly a detectable, but submaximal, tyrosine
phosphorylation of EGFR in HEKn-E6/E7 (Fig. 7A, lanes 5 to
7); this dose was therefore selected to test the ability of UVB
to modulate the receptor’s kinase activity. Treatment of
HEKn-E6/E7 with EGF resulted in the expected coordinated
upregulation of the phosphorylation of EGFR and ERK but
not of JNK (Fig. 7A, lanes 5 to 7). By contrast, irradiation of
the cells with UVB resulted in the upregulation of JNK phos-
phorylation and the inhibition of ERK phosphorylation (Fig.
7A, lanes 2 to 4). However, the inactivation of ERK by UVB
was paralleled by a substantial increase in the phosphorylation
of EGFR on Y1173 (Fig. 7A, lanes 2 to 4). The functional
potentiation of EGFR’s kinase activity by UVB was manifested
by the increase in Y1173 phosphorylation and was accompa-
nied by a detectable shift in the electrophoretic mobility of the
receptor in SDS-PAGE (Fig. 7A, lanes 2 to 4), suggesting that
other tyrosine residues may be phosphorylated in UVB-irradi-
ated keratinocytes as well (Fig. 7B). The UVB-induced inhib-
itory signal to ERK was apparently dominant over the EGF-
induced stimulating signal to ERK (as evidenced by the
inability of EGF to trigger the phosphorylation of ERK in the
UVB-pretreated HEKn-E6/E7 [Fig. 7A, lanes 8 to 10]). We
concluded therefore that UVB interfered with the signaling
pathway that leads to the activation of ERK at a point that is
located upstream of MEK but downstream of EGFR.
To investigate whether UVB causes a functional activation
of EGFR, we employed phospho-specific antibodies and per-
formed analyses of the phosphorylation states of seven of the
nine known tyrosine phosphorylation sites within EGFR. It has
been shown that these phosphotyrosines serve as specific dock-
ing sites for a variety of signal-transducing adaptors and en-
zymes, such as Grb2 and Gab1 (pY1068 and pY1086 [5, 50, 58,
74]), ShcA (pY992, pY1148, and pY1173 [4, 5, 49, 74]), c-Cbl
(pY1045 [39]), PLC- (pY992 [61]), and the AP-2 clathrin
adaptor complex (pY974 [69]). Figure 7B shows that UVB
(1,200 J/m2) caused the substantial phosphorylation of all ty-
rosine residues, with the exception of Y845, tested at 30 min
postirradiation. The levels of tyrosine phosphorylations
achieved by UVB were above those achieved by a “low” dose
of EGF (0.1 ng/ml) that is fully capable of triggering increased
ERK phosphorylation in HEKn-E6/E7 (Fig. 7B, boxed insert).
The less pronounced effect of UVB on the phosphorylation
state of Y845 (Fig. 7B) is likely to result from the fact that this
tyrosine displays a substantial degree of basal phosphorylation
in untreated cells. We concluded that UVB triggers a func-
tional activation of EGFR in keratinocytes and that therefore
the interference of UVB with the EGFR-dependent ERK ac-
tivation must occur downstream of EGFR.
Since Ras proteins are involved in coupling the signal gen-
erated by the ligated EGFR to the kinase cascade composed of
c-Raf, MEK, and ERK, we investigated whether UVB is ca-
pable of modulating Ras activity in keratinocytes. To this end,
we employed Raf-RBD fused to GST. Ras proteins bind Raf-
RBD only in their activated state (i.e., GTP loaded) and are
incapable of binding Raf-RBD in their inactive state (i.e., GDP
loaded) (71). Using agarose beads coupled to GST/Raf-RBD,
we pulled down Ras.GTP from lysates prepared from control
or UVB-irradiated keratinocytes (HEKn and HEKn-E6/E7).
Previous analysis using discriminating antibodies demon-
strated the presence in these cells of p21 H-Ras, p21 K-Ras,
and p23 R-Ras (data not shown). In agreement with the results
of a previous report (28), p23 R-Ras did not display a detect-
able Raf-RBD binding activity (data not shown). Therefore,
FIG. 7. UVB activates EGFR but triggers the functional uncou-
pling of ERK (but not of PKB/Akt1) from EGFR. (A) Immunoblot
analyses with HEKn-E6/E7 placed in BKM–exoGF and treated 2 h
later with UVB (1,200 J/m2), with a dose of EGF that is submaximal
with respect to EGFR phosphorylation (0.1 ng/ml), or with EGF after
a pretreatment with UVB. The phosphorylation statuses of EGFR
(Y1173), ERK, JNK, and PKB/Akt1 (Ser473) were assessed at the
indicated times after the treatments. (B) Immunoblot analyses with
HEKn-E6/E7 handled as described for panel A, except that two doses
of EGF (0.1 ng/ml for experiment 1 and 100 ng/ml for experiment 2)
were applied. The cells were harvested 10 min after the EGF treat-
ments and 30 min after the UVB (1,200 J/m2) treatments (identical
UVB treatments were done in experiments 1 and 2). Lanes 1 to 6, each
panel represents the analysis of the EGFR phosphorylation with phos-
phorylation-specific antibodies against the tyrosine residues indicated
at left. N/A, antibody not available. The boxed insert shows the EGF-
induced phosphorylation of ERK in experiment 1 or 2.
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the combined Raf-RBD-binding activity in keratinocytes (Fig.
8A) was composed predominantly of p21 H-Ras and p21 K-
Ras (Ras activity, for short). Both HEKn and HEKn-E6/E7
displayed a detectable basal activity of Ras (Fig. 8A, lane 1).
Importantly, UVB caused a dose- and time-dependent de-
crease in Ras activity (GTP loading) in both HEKn and
HEKn-E6/E7 (Fig. 8A, lanes 2 to 4). These results demon-
strated that UVB irradiation induced a transient but potent
inhibition of Ras activity in keratinocytes.
Curiously, HaCaT cells also displayed easily detectable lev-
els of basal Ras activity, despite the almost undetectable levels
of ERK phosphorylation in these cells (Fig. 8A, lane 1). Fur-
thermore, following UVB irradiation, HaCaT cells failed to
display an inhibition of their Ras activity (Fig. 8A, lanes 2 to 4).
Consistent with the results reported above (Fig. 1B, lanes 6 to
10), the lack of Ras inactivation was paralleled by a transient
activation of ERK (Fig. 8A, lane 2). These results further
demonstrate that the regulations of the Ras-ERK cascade by
UVB in keratinocytes and HaCaT cells are markedly different.
Next, we investigated the possibility that in HEKn UVB
effected a functional uncoupling of the pathway that joins the
activated EGFR to Ras. The intermediary proteins that con-
stitute this pathway are Grb2, Shc, and Sos. Using an antibody
against Sos1, we were able to coimmunoprecipitate from un-
treated HEKn a multiprotein complex containing Sos1, Grb2,
and all three forms of ShcA (p46, p52, and p66) (Fig. 8B).
Furthermore, under conditions of strong UVB-induced inhibi-
tion of ERK, we failed to detect any disruption of this preex-
isting complex (Fig. 8B), suggesting that UVB did not cause
the inhibition of Ras by disrupting the interactions of Sos with
the adaptor protein Grb2.
We next investigated whether UVB would interfere with the
recruitment of the adaptor proteins Grb2 and ShcA to the
activated EGFR. As expected, the treatment of HEKn with
EGF (100 ng/ml) for 10 min led to the increased association of
ShcA and Grb2 with the phosphorylated EGFR, as demon-
strated by the immunoprecipitation of lysates with an antibody
directed against EGFR and immunodetected, subsequently,
with antibodies directed against ShcA and Grb2 (Fig. 9, lanes
1 and 6 of panels c, d, e, and f). Interestingly, exposure of cells
to UVB (600 to 2,400 J/M2) also led to a dose-dependent
increase in the association of ShcA and Grb2 with EGFR (Fig.
9, lanes 1 to 4 of panels c, d, e, and f), despite the fact that in
the same cells the phosphorylation of MEK and ERK was
strongly inhibited by UVB (Fig. 9, lanes 8 to 10 of panels i and
k).
Inactivation of ERK by ribotoxic stressors in keratinocytes.
We next investigated whether the inactivation of ERK by UV
in keratinocytes is a manifestation of the more general UV-
ribotoxic stress response (31, 33, 34). The ribotoxic stressor
anisomycin (33) triggered a profound dephosphorylation of
ERK in HEKn that was contemporaneous with the induced
phosphorylation of JNK (Fig. 10A, lanes 1 to 9). This aniso-
mycin-triggered dephosphorylation of ERK reflected a strong
(95%) inhibition in the basal catalytic activity of ERK (Fig.
2B). The decrease in the levels of phosphorylated ERK was
detectable between 10 and 20 min after the addition of aniso-
mycin, and it persisted for at least 4 h after treatment (Fig.
10A, lanes 1 to 9). Emetine and pactamycin, two inhibitors of
the UV-ribotoxic stress response (31, 33, 34), completely pre-
vented both the activation of JNK and the inactivation of ERK
by UVB in HEKn (Fig. 10B, lanes 4 to 6). In contrast, actino-
mycin D, an inhibitor of mRNA transcription that does not
affect the ribotoxic stress response (31, 33, 34), failed to pre-
vent UVB from causing both the activation of JNK and the
inactivation of ERK in HEKn (Fig. 10A, lanes 10 to 12). We
have reported previously that emetine specifically inhibits the
ribotoxic, but not the oxidative, stress response in Rat-1 cells
(31, 33, 34). To test whether emetine is a specific inhibitor of
the ribotoxic, but not of the oxidative, stress response in ker-
atinocytes as well, we investigated the regulation of ERK in
FIG. 8. (A) Inhibition of Ras activity by UVB in HEKn and HEKn-
E6/E7 but not in HaCaT cells. Cells (plated and maintained in
BKMexoGF) were irradiated with the indicated doses of UVB, and
the levels of GTP loading of Ras (and ERK phosphorylation in the
case of HaCaT cells) were determined by immunoblot analysis at the
indicated times after the irradiation as described in the text. (B) Ex-
istence of a multiprotein complex containing Sos1, Grb2, and ShcA in
untreated or UVB-treated HEKn. HEKn (grown in BKMexoGF)
were treated with UVB (1,200 J/m2). Sos1 was immunoprecipitated 30
min later, and the presence of Sos1, Grb2, and the three forms of ShcA
(p46, p52, and p66) in the immunoprecipitate was detected in immu-
noblot analyses.
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HEKn by sodium arsenite, an oxidative stressor. Two hours
after addition, arsenite triggered the activation of the SAPKs
JNK1, JNK2, and p38 MAPK and, simultaneously, the inacti-
vation of ERK (Fig. 11A, lane 6). However, emetine was un-
able to inhibit any of the effects of arsenite in HEKn (Fig. 11A,
compare lanes 6 and 7).
Finally, we determined whether emetine would be able to
block the UVB-induced inactivation of Ras. As demonstrated
in Fig. 11B, emetine completely prevented the inactivation of
Ras triggered by UVB (Fig. 11B, compare lanes 1 to 4 with
lanes 5 to 9). Emetine also prevented the UVB-induced inac-
tivation of ERK and the activation of JNK (Fig. 11B, compare
lanes 1 to 4 with lanes 5 to 9). The results presented in Fig. 10
and 11 prompted us to conclude that in keratinocytes the UVB
response of MAP kinases is indeed a manifestation of the more
general ribotoxic stress response.
The phosphorylation of PKB/Akt1 in keratinocytes is main-
tained by autocrine mechanisms via EGFR and is potentiated,
not downregulated, by UVB. Keratinocyte-conditioned me-
dium (BKM–exoGF) contains a secreted factor(s) that trig-
gered a sustained (2 h) phosphorylation of PKB/Akt1 in the
recipient HaCaT cell line (Fig. 5B, lanes 5 to 8), which displays
very low levels of basal phosphorylation of PKB/Akt1 (Fig. 5B,
lanes 1 to 4). Addition of AG1478 to keratinocytes in BKM–
exoGF triggered a complete dephosphorylation of PKB/Akt1
(Fig. 12B, compare lanes 1 and 5), suggesting that the activity
of PKB/Akt1 in keratinocytes is maintained via the autocrine
stimulation of EGFR. In support of this conclusion, treatment
of HEKn-E6/E7 with EGF potently increased the levels of
phosphorylated PKB/Akt1. Interestingly, the lowest dose (0.1
ng/ml) of EGF employed (that was able to cause a detectable
phosphorylation of ERK [Fig. 12A, lanes 5 to 7, and 7A, lanes
5 to 7]) was unable to cause a similar phosphorylation of
PKB/Akt1 (Fig. 12B, lanes 5 to 7, and 7A, lanes 5 to 7). In
contrast to the inhibitory effect of UVB on the Ras-ERK
cascade, UVB irradiation induced the phosphorylation of
PKB/Akt1 (Fig. 7A, lanes 1 to 4, and 12B, lanes 1 to 4). Both
the EGF- and the UVB-induced phosphorylations of PKB/
Akt1 led to the functional activation of the kinase, since both
treatments caused the phosphorylation (on serine 256) of the
FIG. 9. UVB-induced association of the activated EGFR with ShcA, Grb2, and a p55 PI3K. HEKn were maintained in BKMexoGF and were
treated for 30 min with the indicated doses of UVB or for 10 min with the indicated doses of EGF. Lanes 1 to 6, coimmunoprecipitation of the
indicated proteins with EGFR; lanes 7 to 12, cell lysates before the immunoprecipitation. Shown are the results of immunoblot analyses using
antibodies as indicated in each panel. For the detection of ShcA (panels c and d) and Grb2 (panels e and f), the presentation of short and long
film exposures was necessary. IgG, the heavy immunoglobulin chain of the anti-EGFR antibody used for precipitation.
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transcription factor forkhead in rhabdomyosarcoma (FKHR),
a known downstream effector of PKB/Akt1 (56) (Fig. 12A,
lanes 1 to 4, and 12B, lane 1 to 4). Pretreatment of cells with
AG1478 abolished the ability of UVB to cause the phosphor-
ylation of PKB/Akt1 (Fig. 12B, lanes 5 to 8), suggesting that
UVB requires the kinase activity of EGFR to trigger PKB/
Akt1 phosphorylation. The EGFR-neutralizing antibody LA1
inhibited the phosphorylation of PKB/Akt1 within 1 h after
application (Fig. 6A, lane 5). Intriguingly, however, the phos-
phorylation of PKB/Akt1 was restored to the original basal
levels 6 h after the application of LA1 (Fig. 6A, compare lanes
5 and 6), suggesting that a compensatory, EGFR-independent,
mechanism of maintaining the phosphorylated status of PKB/
Akt1 is activated in keratinocytes in response to a prolonged
inhibition of the activity of EGFR.
UVB-specific recruitment of a 55-kDa form of the p85 phos-
phatidylinositide 3-kinase regulatory subunit (PI3K p85 RS)
to the activated EGFR. To investigate the molecular basis for
the UVB-induced activation of PKB/Akt1 in keratinocytes and
the role of EGFR in this process, we studied the recruitment of
PI3K p85 RS to EGFR after UVB and EGF treatments of
HEKn. Mammalian PI3K p85 RS is a family of five different
polypeptides encoded by three different genes: (i) the p85 
protein; (ii) the p85  protein, a product of a different gene;
(iii) the p50  protein, a splice variant of p85 ; (iv) the p55 
protein, another splice variant of p85 ; and (v) the p55 
protein, a product of the p55pik gene (18). All PI3K p85 RS
proteins share a highly homologous region consisting of two
SH2 domains and an inter-SH2 domain (18). Using a pan-p85
RS antibody that recognizes all five polypeptides, we observed
that a single form of PI3K p85 RS with an apparent molecular
mass of 55 kDa associated with EGFR specifically after the
UVB irradiation but, surprisingly, not after the treatment with
EGF (Fig. 9, lanes 1 to 6 of panels g and h [the binding of the
55 kDa form of PI3K p85 RS is obvious in lanes 3 and 4 above
the interfering immunoglobulin heavy-chain band]). Whether
the p55 protein represents p55  or p55  remains to be
elucidated. Neither the p85 / nor the p50  forms associated
with EGFR under the experimental conditions employed for
immunoprecipitation (Fig. 9, lanes 1 to 6 of panels g and h).
DISCUSSION
The most important findings of the research presented here
can be summarized as follows: (i) normal human keratinocytes
display high levels of ERK activity that is sustained via the
autocrine production of an EGFR ligand(s); (ii) keratinocytes
respond to UVB irradiation with a stimulation of EGFR ac-
tivity above the levels normally maintained by autocrine acti-
vation; (iii) the UVB-induced activation of EGFR is followed,
FIG. 10. The ribotoxic stress response of human keratinocytes.
(A) Immunoblot analyses with HEKn (plated and maintained in
BKMexoGF) treated with anisomycin (10 g/ml) (lanes 1 to 9) or
with UVB (1,200 J/m2) (lanes 11 and 12) in the absence or in the
presence of a pretreatment (30 min) with actinomycin D (20 M). The
phosphorylation statuses of JNK and ERK were determined at the
indicated times after the treatments. (B) Immunoblot analyses with
HEKn treated with UVB (1,200 J/m2) in the absence or in the presence
of a pretreatment (5 min) with either emetine (Em; 100 g/ml) or
pactamycin (Pa; 0.2 g/ml). The phosphorylation statuses of JNK and
ERK were determined 30 min after the irradiation.
FIG. 11. The ribotoxic stress response of human keratinocytes.
(A) Immunoblot analyses with HEKn (plated and maintained in
BKMexoGF) treated with UVB (1,200 J/m2) or sodium arsenite (200
g/ml) in the absence or in the presence of a pretreatment (5 min) with
emetine (Em, 100 g/ml). The phosphorylation statuses of p38 MAP
kinase, JNK, and ERK were determined at the indicated times after
the treatments. –, cells pretreated with the vehicle solvent DMSO.
(B) Immunoblot analyses with HEKn-E6/E7 (plated and maintained in
BKMexoGF) treated with UVB (1,200 J/m2) in the absence or in the
presence of a pretreatment (5 min) with emetine (100 g/ml). RasGTP
levels were determined at the indicated times after the treatments as
shown in Fig. 8A. The phosphorylation statuses of JNK and ERK were
assessed from the same cell lysates before the precipitation of Ras with
GST/Raf-RBD.
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unexpectedly, by a rapid and potent inactivation of ERK; (iv)
the inactivation of ERK correlates with a UVB-induced (and
yet-to-be-identified) signal transduction event that uncouples
the EGFR-recruited ShcA and Grb2 from Ras; and (v) the
UVB-induced inactivation of the Ras-ERK cascade in keratin-
ocytes belongs to the more general ribotoxic stress response.
To our knowledge, this is the first report showing that the
functional activation of EGFR need not invariably result in an
elevated ERK activity and that it may coincide even with an
inhibition of ERK activity. We discuss here both the mecha-
nisms of this inhibition and its potential physiological implica-
tions.
We have found that both HEKn and HEKn-E6/E7 appeared
to maintain high basal activity of ERK even in the absence of
exogenous growth factors (Fig. 3B and 4B). The most likely
reason for the high basal activity of ERK in proliferating ker-
atinocytes is the autocrine production of soluble growth fac-
tor(s) (Fig. 4A and 5B). Furthermore, based on the use of
AG1478 and of the EGFR-neutralizing antibody, we con-
cluded that these factors signal through EGFR. On the other
hand, HaCaT cells, a human keratinocyte-derived cell line, (i)
have lost the ability to produce an autocrine EGFR ligand(s)
(Fig. 4A and 5B), (ii) proliferate poorly even in complete
keratinocyte medium (BKMexoGF) (data not shown), and
(iii) proliferate significantly better in the presence of growth
factors supplied by fetal calf serum (data not shown). Taken
together, these observations make a convincing argument that
the autocrine production of an EGFR ligand(s) is critically
important for the proliferation and homeostasis of human ker-
atinocytes. Evidence from mice with manipulated egfr alleles
(hypomorphic, dominant-negative, or null) suggests that
EGFR provides both proliferative and survival signals for the
basal keratinocytes in mouse skin (reference 68 and references
therein). It has been reported that keratinocytes produce four
EGFR ligands, namely TGF- (11), amphiregulin (13), HB-
EGF (25), and epiregulin (67). We are currently investigating
the identity of the factors that maintain the high basal levels of
ERK activity in HEKn and HEKn-E6/E7.
Using NIH 3T3 mouse fibroblasts and HeLa cells, ERK was
identified as the first MAP kinase whose activation was able to
be detected early after irradiation with UVC radiation (55).
The identification of the ability of UVC to trigger the activa-
tion of EGFR (36, 63) gave further credence to the concept of
an operational EGFR-ERK cascade as an important mediator
of the UV-induced gene expression (6, 26). Evidence has been
presented that the ability of UVC and UVB to activate EGFR
resulted from the UV-induced incapacitation of protein phos-
phatases (36). We demonstrate here for the first time that
UVB causes the inactivation, rather than activation, of ERK in
normal human keratinocytes. The wavelength of the radiation
used (UVC versus UVB) cannot account for the differences in
ERK behavior, since we have observed the same potent inac-
tivation of ERK in keratinocytes with UVC and with UVB
(data not shown) and since both UVC and UVB activate
EGFR (36). Therefore, we conclude that it is the cell type and
not the type of UV radiation that determines the direction of
the response of ERK.
A striking finding in our experiments was that the activation
of EGFR in keratinocytes by UVB (Fig. 7B) did not result in
the subsequent activation of Ras and ERK but rather in their
inactivation. We propose that an important role in this process
is played by a UVB-triggered event that uncouples the func-
tionally EGFR-recruited adaptor proteins ShcA and Grb2
(Fig. 9) from the activation of Ras (Fig. 8A). Grb2 contains
one SH2 domain flanked by two SH3 domains (42). The SH2
domain of Grb2 binds to tyrosine-phosphorylated residues in
growth factor receptors, such as Y1068 and Y1086 of EGFR
(5, 50, 74), whereas the SH3 domains bind to proline-rich
motifs found in many signaling molecules, such as Sos (9, 52).
Sos is a guanine nucleotide exchange factor that greatly in-
creases the activation of Ras in response to activation of
growth factor receptors (9). Since we failed to detect a UVB-
induced disruption of the interaction of Sos with Grb2 and
ShcA (Fig. 8B), it is likely that the Sos-Grb2 association is not
the relevant target of the UVB-triggered inhibitory signal. It is
possible that UVB interferes with the enzymatic activities of
Sos and/or Ras GAP proteins (for a review, see reference 71).
Since the UVB response of keratinocytes has both stimula-
tory (activation of SAPK) and inhibitory (inactivation of ERK)
signal transduction components, it is reasonable to ask whether
FIG. 12. Activation of PKB/Akt1 in response to EGF and UVB in
keratinocytes. (A) Immunoblot analyses with HEKn-E6/E7 placed in
BKM–exoGF overnight and treated with low (0.1 ng/ml) or high (10
ng/ml) doses of EGF. The phosphorylation statuses of ERK, PKB/
Akt1 (Ser473), and FKHR (Ser256) were assessed at the indicated
times after the treatments. (B) Immunoblot analyses with HEKn-
E6/E7 placed in BKM–exoGF and treated 2 h later with UVB (1,200
J/M2) in the absence (–) or presence () of a 30-min pretreatment with
AG1478 (10 M). The phosphorylation statuses of ERK, PKB/Akt1
(Ser473), and FKHR (Ser256) were assessed at the indicated times
after the treatments.
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the two components originate from the same primary event
(e.g., the interaction of UVB with the same sensory chro-
mophore). Recent studies using nonepidermal cells have sug-
gested that ribosomes actively engaged in translational elon-
gation may be the cellular structures where the UV-induced
signal leading to the activation of SAPK is initiated (31, 34).
The results presented in Fig. 10 and 11 strongly suggest that
both the stimulatory (activation of SAPK) and the inhibitory
(inactivation of ERK) signal transduction components of the
UVB response in keratinocytes require active ribosomes to
occur. Interestingly, while the activation of SAPK by UVB is
invariant in nonepidermal cells as well as in keratinocytes (31,
34), the UVB response of ERK is markedly different. In non-
epidermal cells, UVC and UVB stimulated the activity of ERK
in a way that required growth factor receptors but did not
require active ribosomes (31, 34; unpublished data). In con-
trast, keratinocytes require EGFR to maintain the basal activ-
ity of ERK but require active ribosomes for the UVB-induced
inhibition of ERK activity.
Although the UVB-induced inhibition of ERK is invariant in
its occurrence in all experiments that we have performed in
HEKn or HEKn-E6/E7, the duration of this inhibition was
subject to some variation from experiment to experiment. Fur-
thermore, while we have observed a precise temporal correla-
tion between the onsets of inhibitions of Ras and of ERK
whenever these analyses have been performed in parallel, we
have observed that the basal activity of Ras tends to be re-
stored faster than that of ERK. For instance, 2 h after irradi-
ation of keratinocytes with 1,200 J/m2 of UVB, the activity of
Ras was typically similar to the basal Ras activity (Fig. 8A). At
the same time, the phosphorylation of ERK in most experi-
ments did not reach basal levels until at least 4 to 6 h after the
irradiation (Fig. 3A). These results suggest that the activity of
ERK in keratinocytes may be regulated by UVB at a more
complex level than the activity of Ras alone.
Observations with mice with a genetic inactivation of the egfr
gene have demonstrated the involvement of this receptor in
the development of normal mouse skin (reference 68 and ref-
erences therein). However, similar genetic evidence for the
possible roles of ERK in the development of the mouse skin is
still lacking. Particularly insufficient is our knowledge of the
involvement of the EGFR-Ras-ERK cascade in the mainte-
nance of skin homeostasis in long-lived mammals such as hu-
mans. However, indirect evidence strongly suggests that the
proliferative state of basal keratinocytes in human skin cru-
cially depends on the activity of the EGFR-Ras-ERK cascade.
For instance, phosphorylated ERK has been detected, via im-
munohistochemical methods, almost exclusively in the stratum
basale, the proliferative compartment of the skin harboring the
keratinocyte stem cells (see below) (1, 70). Furthermore, ab-
normally increased phosphorylation of ERK in the stratum
spinosum has been observed in cases of psoriasis, a disorder
that is characterized by a keratinocyte hyperproliferation in the
suprabasal layers (24). Finally, patients enrolled in clinical
trials of blocking anti-EGFR antibodies for the treatment of
head-and-neck cancer displayed a marked decrease of ERK
phosphorylation in the stratum basale. This decrease in ERK
phosphorylation correlated with a dramatic decrease in the
proliferation of basal keratinocytes (1). In view of the above-
mentioned observations, we propose that the inactivation of
the Ras-ERK pathway in proliferating basal keratinocytes
(particularly in epidermal stem cells; see below) may provide
an important initial signal arresting the cell cycle progression
of cells that have not yet entered S phase (Fig. 13). The model
shown in Fig. 13 is supported by the rapid (50% within 2 h)
decrease in the proportion of keratinocytes engaged in DNA
synthesis after irradiation with UVB (unpublished data). It is
thought that the major mediator of cell cycle arrest in UV-
irradiated cells is the p53 tumor suppressor (29). Surprisingly,
we found that UVB irradiation of HEKn (p53-proficient cells
[Fig. 2A, lanes 1 to 5]) and HEKn-E6/E7 (p53-deficient cells
[Fig. 2A, lanes 6 to 10]) resulted in a similar rapid decrease in
the [3H]thymidine incorporation in both cell types (unpub-
lished data). These results suggest that a p53-independent
mechanism of cell cycle arrest is operational in UVB-irradi-
ated keratinocytes. In support of the hypothesis that this p53-
independent signal triggering a cell cycle arrest in irradiated
keratinocytes may indeed be provided by the inhibition of
ERK activity, we have found that the steady-state levels of
cyclin D1 decline substantially in UVB-irradiated keratino-
cytes. It has been found that the expression of cyclin D1 re-
quires the sustained activity of ERK (3, 76). Therefore, it is
intriguing to speculate that even a transient inhibition of ERK
activity in response to UVB may trigger a prolonged decline in
the cyclin D1 levels (Fig. 3A).
Epidermal stem cells (i.e., cells that remain in stratum basale
after each cell division and retain their full proliferative po-
FIG. 13. A model for the selective interference of UVB radiation
with the EGFR-dependent signal transduction in keratinocytes. (A) In
the absence of UVB, the autocrine stimulation of EGFR maintains an
active Ras-ERK cascade that is involved in cell proliferation (see
Discussion). (B) EGFR also generates an antiapoptotic signal that is
mediated via the PI3K-PKB/Akt1 cascade (reference 68 and refer-
ences therein). UVB irradiation causes the selective inactivation of the
Ras-ERK cascade, whereas the signal transduction pathway leading to
the activation of PKB/Akt1 remains intact (or is even stimulated [Fig.
12]).
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tential) in the skin of long-lived mammalian organisms are
likely to have developed unique ways to deal with repeated
episodes of acute encounter with solar radiation. Suprabasal
cells, such as differentiating or fully differentiated keratino-
cytes, can be eliminated by apoptosis (sunburn cells) without
lasting consequences for the organism. However, shunting stra-
tum basale stem cells into apoptosis after repeated episodes of
acute irradiation may lead to a gradual depletion of the epi-
dermis of stem cells, thereby severely hampering the continu-
ous renewal of the skin. At the other extreme, tipping the
balance toward increased survival after an encounter with a
potent mutagen such as UVB carries the risk of a malignant
transformation of the epidermal stem cell (thus leading to
epidermal carcinomas). It seems likely that one sound strategy
for fostering the survival of UVB-irradiated epidermal stem
cells without the accumulation of mutations would be to arrest
their cell cycle progression before they enter S phase (while
actively suppressing apoptosis) until the DNA damage has
been repaired. Upon completion of DNA repair, the epider-
mal stem cells (having been spared apoptotic cell death) can
resume their important role of providing a continuous supply
of differentiation-committed suprabasal keratinocytes. The
newly described phenomenon of the UVB-induced uncoupling
of the signaling pathway leading from EGFR to the activation
of ERK presented here may suggest one possible mechanism
executing exactly such a complex response to UVB. This hy-
pothesis is outlined in Fig. 13. In proliferating basal keratino-
cytes, the low-level but persistent activation of EGFR (due to
autocrine EGFR ligands) provides survival (antiapoptotic) and
proliferative signals. The antiapoptotic program may be medi-
ated through the sustained activity of the EGFR-PI3K-PKB/
Akt1 cascade, whereas the mitogenic program may be medi-
ated through the EGFR-Ras-ERK cascade (reference 68 and
references therein) (Fig. 13A). By uncoupling EGFR from the
Ras-ERK cascade, UVB may trigger the growth arrest pro-
gram of the cell (Fig. 13B). At the same time, by stimulating
the intrinsic tyrosine kinase activity of EGFR, UVB may po-
tentiate the necessary survival signals, mediated by an EGFR-
driven activation of PKB/Akt1, to prevent apoptosis (Fig. 13B).
The experimental testing of this hypothesis is under way.
Finally, it should be noted that with regard to the respon-
siveness of ERK signaling to UVB, the HaCaT cell line be-
haves like fibroblasts and HeLa cells but unlike HEKn and
HEKn-E6/E7. Cell lines selected by atypical culture conditions
(e.g., serum-dependent growth in the case of HaCaT cells) thus
may not provide useful (under some circumstances) models for
the study of tissue-specific responses to toxic metabolites, car-
cinogens, and environmental stresses. The results presented
here underscore the need for the development of suitable
human tissue explants for studying these responses.
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